Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Maryam Azimi Mohammadabadi, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mansourabadi AH, Aghamajidi A, Faraji F, Taghizadeh S, Mohamed Khosroshahi L, Bahramkiya M, Azimi M. Mesenchymal stem cells- derived exosomes inhibit the expression of Aquaporin-5 and EGFR in HCT-116 human colorectal carcinoma cell line. BMC Mol Cell Biol. 2022 Sep 16; 23(1):40. PMID: 36114463; PMCID: PMC9479423.
    Citations:    Fields:    Translation:HumansCells
  2. Khoshmirsafa M, Assarehzadegan MA, Fallahpour M, Azimi M, Faraji F, Riahi T, Minaeian S, Fassahat D, Divsalar F, Abbasi MA. Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity. Viral Immunol. 2022 Aug 23. PMID: 35997599.
    Citations:    Fields:    
  3. Azimi M, Keshavarz Shahbaz S, Mansourabadi AH, Mohamed Khosroshahi L, Pourkalhor S, Rezakhani M, Masoumi F. Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer. Int Arch Allergy Immunol. 2022; 183(11):1147-1165. PMID: 35988536.
    Citations: 1     Fields:    Translation:Humans
  4. Taghizadeh S, Motallebnezhad M, Aghaie T, Azimi M, Aghamajidi A, Salari AA, Bozorgmehr M, Assarezadegan MA, Jazayeri MH. Anti-Caspr-conjugated gold nanoparticles emergence as a novel approach in the treatment of EAE animal model. Metab Brain Dis. 2022 10; 37(7):2603-2613. PMID: 35922733.
    Citations:    Fields:    Translation:Animals
  5. Khorramdelazad H, Kazemi MH, Azimi M, Aghamajidi A, Mehrabadi AZ, Shahba F, Aghamohammadi N, Falak R, Faraji F, Jafari R. Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019. Eur J Pharmacol. 2022 Jul 15; 927:175051. PMID: 35618037; PMCID: PMC9124632.
    Citations:    Fields:    Translation:HumansCells
  6. Rezaei Kahmini F, Shahgaldi S, Azimi M, Mansourabadi AH. Emerging therapeutic potential of regulatory T (Treg) cells for rheumatoid arthritis: New insights and challenges. Int Immunopharmacol. 2022 Jul; 108:108858. PMID: 35597122.
    Citations:    Fields:    Translation:HumansCells
  7. Baharlooi H, Mansourabadi AH, Minbashi Moeini M, Mohamed Khosroshahi L, Azimi M. Nucleic Acids as Novel Therapeutic Modalities to Address Multiple Sclerosis Onset and Progression. Cell Mol Neurobiol. 2022 Nov; 42(8):2611-2627. PMID: 34694513.
    Citations:    Fields:    Translation:Humans
  8. Rahimzadeh P, Mortezagholi S, Ghayedi M, Namdari H, Rahimzadeh M, Boghozian R, Azimi M, Salehi E. Induction of Systemic Lupus Erythematosus-like Syndrome in BALB/c Mice Leads to Disturbance in Splenic T Cell Subpopulations. Iran J Allergy Asthma Immunol. 2021 Sep 28; 20(5):584-592. PMID: 34664817.
    Citations:    Fields:    Translation:AnimalsCells
  9. Pourhajibagher M, Azimi M, Haddadi-Asl V, Ahmadi H, Gholamzad M, Ghorbanpour S, Bahador A. Robust antimicrobial photodynamic therapy with curcumin-poly (lactic-co-glycolic acid) nanoparticles against COVID-19: A preliminary in vitro study in Vero cell line as a model. Photodiagnosis Photodyn Ther. 2021 Jun; 34:102286. PMID: 33838311.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  10. Baharlooi H, Salehi Z, Minbashi Moeini M, Rezaei N, Azimi M. Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis. Adv Pharm Bull. 2022 Mar; 12(2):389-397. PMID: 35620339.
    Citations:    
  11. Baharlooi H, Nouraei Z, Azimi M, Moghadasi AN, Tavassolifar MJ, Moradi B, Sahraian MA, Izad M. Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis. Scand J Immunol. 2021 Jun; 93(6):e13013. PMID: 33338274.
    Citations: 7     Fields:    Translation:HumansCells
  12. Gholamzad M, Baharlooi H, Shafiee Ardestani M, Seyedkhan Z, Azimi M. Prophylactic and Therapeutic Effects of MOG-Conjugated PLGA Nanoparticles in C57Bl/6 Mouse Model of Multiple Sclerosis. Adv Pharm Bull. 2021 May; 11(3):505-513. PMID: 34513625.
    Citations:    
  13. Baharlooi H, Azimi M, Salehi Z, Izad M. Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases. Int J Stem Cells. 2020 Mar 30; 13(1):13-23. PMID: 31887849.
    Citations: 21     
  14. Makoui MH, Imani D, Motallebnezhad M, Azimi M, Razi B. Vitamin D receptor gene polymorphism and susceptibility to asthma: Meta-analysis based on 17 case-control studies. Ann Allergy Asthma Immunol. 2020 01; 124(1):57-69. PMID: 31654764.
    Citations: 11     Fields:    Translation:Humans
  15. Azimi M, Ghabaee M, Naser Moghadasi A, Izad M. Altered Expression of miR-326 in T Cell-derived Exosomes of Patients with Relapsing-remitting Multiple Sclerosis. Iran J Allergy Asthma Immunol. 2019 Feb; 18(1):108-113. PMID: 30848579.
    Citations: 16     Fields:    Translation:HumansCells
  16. Gholamzad M, Ebtekar M, Ardestani MS, Azimi M, Mahmodi Z, Mousavi MJ, Aslani S. A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future. Inflamm Res. 2019 Jan; 68(1):25-38. PMID: 30178100.
    Citations: 36     Fields:    Translation:HumansAnimalsCells
  17. Azimi M, Ghabaee M, Moghadasi AN, Noorbakhsh F, Izad M. Immunomodulatory function of Treg-derived exosomes is impaired in patients with relapsing-remitting multiple sclerosis. Immunol Res. 2018 08; 66(4):513-520. PMID: 29882035.
    Citations: 26     Fields:    Translation:HumansCells
  18. Rashid Chehreh Bargh S, Tafakhori A, Masoumi F, Rahmani F, Ahmadi M, Namdar A, Azimi M, Tavasolian P, Habibi S, Zamani B, Maserrat M, Sadr M, Noorbakhsh F, Rezaei N. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis. Ir J Med Sci. 2018 Nov; 187(4):1065-1071. PMID: 29574662.
    Citations: 2     Fields:    Translation:HumansCells
  19. Azimi M, Aslani S, Mortezagholi S, Salek A, Javan MR, Rezaiemanesh A, Ghaedi M, Gholamzad M, Salehi E. Identification, Isolation, and Functional Assay of Regulatory T Cells. Immunol Invest. 2016 Oct; 45(7):584-602. PMID: 27420738.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  20. Mortezagholi S, Babaloo Z, Rahimzadeh P, Ghaedi M, Namdari H, Assar S, Azimi Mohamadabadi M, Salehi E. Evaluation of PBMC Distribution and TLR9 Expression in Patients with Systemic Lupus Erythematosus. Iran J Allergy Asthma Immunol. 2016 Jun; 15(3):229-36. PMID: 27424138.
    Citations: 7     Fields:    Translation:HumansCellsCTClinical Trials
  21. Azimi M, Nafissi-Varcheh N, Faramarzi MA, Aboofazeli R. Laccase Activity in CTAB-Based Water-in-Oil Microemulsions. Iran J Pharm Res. 2016; 15(3):441-452. PMID: 27980579; PMCID: PMC5149031.
    Citations: 2     
  22. Azimi M, Aghamohammadi A, Ochs HD, Rezaei N. Soluble molecules in intravenous immunoglobulin: benefits and limitations. Expert Rev Clin Immunol. 2016; 12(2):99-101. PMID: 26648398.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  23. Ghaedi M, Namdari H, Rahimzadeh P, Morteza Gholi S, Azimi Mohamadabadi M, Salehi E. Different Doses of Transforming growth factor-ß on In vitro Differentiation of Human Naïve CD4+ T Cells to T Helper 17. Iran J Allergy Asthma Immunol. 2015 Dec; 14(6):633-7. PMID: 26725561.
    Citations: 2     Fields:    Translation:HumansCells
  24. Azimi Mohamadabadi M, Hassan ZM, Zavaran Hosseini A, Gholamzad M, Noori S, Mahdavi M, Maroof H. Arteether exerts antitumor activity and reduces CD4+CD25+FOXP3+ T-reg cells in vivo. Iran J Immunol. 2013 Sep; 10(3):139-49. PMID: 24076591.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  25. Azimi Mohamadabadi M, Hassan ZM, Zavaran Hosseini A, Noori S, Mahdavi M, Maroufizadeh S, Maroof H. Study of immunomodulatory effects of arteether administrated intratumorally. Iran J Allergy Asthma Immunol. 2013 Mar; 12(1):57-62. PMID: 23454779.
    Citations:    Fields:    Translation:AnimalsCells
  26. Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol. 2012 Dec; 32(6):1353-9. PMID: 22711009.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Azimi Mohammadabadi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (124)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.